These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 9705578

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Stimulation of the hypothalamic-pituitary-adrenal axis by epidermal growth factor.
    Miyabo S, Ooya E, Miyanaga K, Aoyagi N, Hirai M, Kishida S, Nakai T.
    Regul Pept; 1990 Oct 29; 31(1):65-74. PubMed ID: 2176727
    [Abstract] [Full Text] [Related]

  • 43. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog.
    Inoue T, Inui A, Okita M, Sakatani N, Oya M, Morioka H, Mizuno N, Oimomi M, Baba S.
    Life Sci; 1989 Oct 29; 44(15):1043-51. PubMed ID: 2538698
    [Abstract] [Full Text] [Related]

  • 44. Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat.
    Turnbull AV, Rivier C.
    Endocrinology; 1996 Feb 29; 137(2):455-63. PubMed ID: 8593789
    [Abstract] [Full Text] [Related]

  • 45. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G, Ixart G, Tapia-Arancibia L, Givalois L.
    Neuroscience; 2006 May 12; 139(2):779-89. PubMed ID: 16457953
    [Abstract] [Full Text] [Related]

  • 46. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J, Grino M, Bernet F, Dutriez-Casteloot I, Montel V, Dupouy JP.
    J Neuroendocrinol; 1998 May 12; 10(5):331-42. PubMed ID: 9663647
    [Abstract] [Full Text] [Related]

  • 47. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ, Edwards E, Nemeroff CB.
    Eur J Pharmacol; 1990 Nov 06; 190(1-2):113-22. PubMed ID: 1963847
    [Abstract] [Full Text] [Related]

  • 48. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb 06; 256(2):795-800. PubMed ID: 1847213
    [Abstract] [Full Text] [Related]

  • 49. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J, Borycz J, Gadek-Michalska A, Głód R.
    J Physiol Pharmacol; 1998 Dec 06; 49(4):607-16. PubMed ID: 10069701
    [Abstract] [Full Text] [Related]

  • 50. Constant light and dark affect the circadian rhythm of the hypothalamic-pituitary-adrenal axis.
    Fischman AJ, Kastin AJ, Graf MV, Moldow RL.
    Neuroendocrinology; 1988 Apr 06; 47(4):309-16. PubMed ID: 2836747
    [Abstract] [Full Text] [Related]

  • 51. Role of nitric oxide in regulating the rat hypothalamic-pituitary-adrenal axis response to endotoxemia.
    Rivier C.
    Ann N Y Acad Sci; 2003 May 06; 992():72-85. PubMed ID: 12794048
    [Abstract] [Full Text] [Related]

  • 52. Effect of excitatory amino acid on the hypothalamo-pituitary-adrenal axis in the rat during the stress-hyporesponsive period.
    Chautard T, Boudouresque F, Guillaume V, Oliver C.
    Neuroendocrinology; 1993 Jan 06; 57(1):70-8. PubMed ID: 8097578
    [Abstract] [Full Text] [Related]

  • 53. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S.
    Neuroendocrinology; 2000 Jun 06; 71(6):366-74. PubMed ID: 10878498
    [Abstract] [Full Text] [Related]

  • 54. Corticotropin-releasing activity of gastrin-releasing peptide in normal men.
    Knigge U, Holst JJ, Knuhtsen S, Bach FW, Bang P.
    J Clin Endocrinol Metab; 1987 Dec 06; 65(6):1291-5. PubMed ID: 2824553
    [Abstract] [Full Text] [Related]

  • 55. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis.
    Gwosdow AR, Kumar MS, Bode HH.
    Am J Physiol; 1990 Jan 06; 258(1 Pt 1):E65-70. PubMed ID: 2154118
    [Abstract] [Full Text] [Related]

  • 56. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA, Biscardi R, Smith MD, Wilson SP.
    J Pharmacol Exp Ther; 1996 Sep 06; 278(3):1073-82. PubMed ID: 8819488
    [Abstract] [Full Text] [Related]

  • 57. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL, Millan MA, Lorang M, Harwood JP, Aguilera G.
    Endocrinology; 1988 Jul 06; 123(1):396-405. PubMed ID: 2838259
    [Abstract] [Full Text] [Related]

  • 58. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
    Seal LJ, Small CJ, Dhillo WS, Kennedy AR, Ghatei MA, Bloom SR.
    Neuroendocrinology; 2002 Aug 06; 76(2):70-8. PubMed ID: 12169768
    [Abstract] [Full Text] [Related]

  • 59. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat.
    Schlussman SD, Zhou Y, Johansson P, Kiuru A, Ho A, Nyberg F, Kreek MJ.
    Neurosci Lett; 2000 Apr 28; 284(3):190-4. PubMed ID: 10773431
    [Abstract] [Full Text] [Related]

  • 60. Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses.
    Lee S, Selvage D, Hansen K, Rivier C.
    Endocrinology; 2004 Oct 28; 145(10):4470-9. PubMed ID: 15205375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.